Researchers in Calgary are preparing to begin a new study to see whether a commonly available acne medication could help delay the crippling effects of multiple sclerosis. Now, clinical researchers in 14 Canadian centres will be taking an in-depth look at the drug in a $4-million, two-year study funded by the MS Society of Canada. But the drug also offers anti-inflammatory properties, which researchers believe are responsible for its ability to slow the progress of MS. The smaller study found that the drug substantially reduced the activity of the lesions that develop on MS patients’ brains and spinal tissues. Enrollment for the 200 patients needed for the study is set to begin in January, 2008, and will take place in 14 health centres across Canada. read more
Technorati Tags: study, minocycline, ms, researchers, drug, clinical, acne news
This entry was posted
on Wednesday, October 31st, 2007 at 4:36 am and is filed under Acne News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.